We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
694
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALC icon
3976
CalciMedica
CALC
$19.1M
$57K ﹤0.01%
3,721
+1,197
+47% +$16.3K
FRGT icon
3977
Freight Technologies
FRGT
$1.38M
0
ITP icon
3978
IT Tech Packaging
ITP
$2.91M
$57K ﹤0.01%
48,395
-82,972
-63% -$190K
ALZN icon
3979
Alzamend Neuro
ALZN
$6.9M
$56K ﹤0.01%
+48
New +$62.2K
LGL.WS
3980
DELISTED
LGL Group Inc Warrants
LGL.WS
$56K ﹤0.01%
120,259
-5,000
-4% -$2.45K
MYSZ icon
3981
My Size
MYSZ
$2.01M
$56K ﹤0.01%
1,474
-173
-11% -$9K
SCPS
3982
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$56K ﹤0.01%
130,852
+18,329
+16% +$8.81K
HSDT icon
3983
Solana Company
HSDT
$102M
$55K ﹤0.01%
1
CNSY
3984
Cerenome, Inc. Common Stock
CNSY
$25.5M
$55K ﹤0.01%
270
+90
+50% +$22.5K
CORR
3985
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$55K ﹤0.01%
+21,800
New +$58.8K
BJDX icon
3986
Bluejay Diagnostics
BJDX
$1.09M
$54K ﹤0.01%
+2
New +$70.9K
ONCS
3987
DELISTED
OncoSec Medical Incorporated
ONCS
$54K ﹤0.01%
3,314
+1,087
+49% +$20.9K
IMH
3988
DELISTED
Impac Mortgage Holdings Inc.
IMH
$53K ﹤0.01%
90,771
+800
+0.9% +$568
DUO
3989
Fangdd Network Group
DUO
$24.9M
$52K ﹤0.01%
110
+52
+90% +$43.1K
SXTC icon
3990
China SXT Pharmaceuticals
SXTC
$1.76M
0
WRN
3991
Western Copper and Gold
WRN
$542M
$52K ﹤0.01%
39,060
-457,303
-92% -$830K
XTIA icon
3992
XTI Aerospace
XTIA
$61.9M
0
INDP icon
3993
Indaptus Therapeutics
INDP
$136M
$51K ﹤0.01%
+700
New +$54.7K
BLNE
3994
Beeline Holdings
BLNE
$35.8M
$51K ﹤0.01%
368
-342
-48% -$56.2K
GRI
3995
GRI Bio
GRI
$3.45M
0
RSI icon
3996
Rush Street Interactive
RSI
$2.81B
$50K ﹤0.01%
10,600
-569,300
-98% -$3.39M
UNAM
3997
DELISTED
Unico American Corp
UNAM
$50K ﹤0.01%
23,137
-200
-0.9% -$486
CNET icon
3998
ZW Data Action Technologies
CNET
$4.88M
$49K ﹤0.01%
7,235
+6,405
+772% +$55.4K
OUST icon
3999
Ouster
OUST
$3.33B
$49K ﹤0.01%
+3,031
New +$85K
SMMT icon
4000
Summit Therapeutics
SMMT
$12B
$49K ﹤0.01%
+49,118
New +$68.9K

Similar funds

Jim Simons's Q2 2022 Portfolio in Review

As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
  • Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Jim Simons opened 694 new positions and closed 562 in Q2 2022.
  • Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.